Rivaroxaban reduces ischaemic events in patients with PAD
- PMID: 32296145
- DOI: 10.1038/s41569-020-0385-9
Rivaroxaban reduces ischaemic events in patients with PAD
Comment on
-
Vascular toxic effects of cancer therapies.Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. Nat Rev Cardiol. 2020. PMID: 32218531 Free PMC article. Review.
-
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
References
Original article
-
- Bonaca, M. P. et al. Rivaroxaban in peripheral artery disease after revascularization. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2000052 (2020) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
